taxonomy (1)
protein (1)
source (2)
structure (0)
composition (16)
disease (1)
reference (2)
site (6)
peptide (6)
- Homo sapiens (Human)
Taxonomy
- Mammary Gland (UBERON_0001911)
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
Source
Reported structure
- Hex:3 HexNAc:2 (avg mass : 910.8325 )
- Hex:3 HexNAc:2 dHex:1 (avg mass : 1056.9755 )
- Hex:4 HexNAc:3 NeuAc:1 (avg mass : 1567.4278 )
- Hex:4 HexNAc:3 dHex:1 NeuAc:1 (avg mass : 1713.5708 )
- Hex:4 HexNAc:3 dHex:2 (avg mass : 1568.4559 )
- Hex:4 HexNAc:3 dHex:3 (avg mass : 1714.5989 )
- Hex:5 HexNAc:2 (avg mass : 1235.1173 )
- Hex:5 HexNAc:2 dHex:1 (avg mass : 1381.2603 )
- Hex:5 HexNAc:3 NeuAc:1 (avg mass : 1729.5702 )
- Hex:5 HexNAc:3 dHex:2 (avg mass : 1730.5983 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:6 HexNAc:2 (avg mass : 1397.2597 )
- Hex:6 HexNAc:3 NeuAc:1 (avg mass : 1891.7126 )
- Hex:6 HexNAc:3 dHex:2 (avg mass : 1892.7407 )
- Hex:7 HexNAc:2 (avg mass : 1559.4021 )
- Hex:12 HexNAc:2 (avg mass : 2370.1141 )
Composition
- Cancer, breast (DOID:1612)
Disease
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
Reference
- Lysosomal alpha-mannosidase / Homo sapiens
Reported glycosite
-
- Hex:3 HexNAc:2 / N-Linked (avg mass : 910.8325)
- Mammary Gland (UBERON_0001911)
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
- Cancer, breast (DOID:1612)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
- Lysosomal alpha-mannosidase / Homo sapiens
- ANITWSVK (8aa)
- TPIVQEVHQNFSAWCSQVVR (20aa)
- NLSAPVTLNLR (11aa)
-
- Hex:3 HexNAc:2 dHex:1 / N-Linked (avg mass : 1056.9755)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Lysosomal alpha-mannosidase / Homo sapiens
- INQTEPVAGNYYPVNTR (17aa)
-
- Hex:5 HexNAc:2 / N-Linked (avg mass : 1235.1173)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Lysosomal alpha-mannosidase / Homo sapiens
- ANITWSVK (8aa)
- TPIVQEVHQNFSAWCSQVVR (20aa)
-
- Hex:5 HexNAc:2 dHex:1 / N-Linked (avg mass : 1381.2603)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Lysosomal alpha-mannosidase / Homo sapiens
- NLSAPVTLNLR (11aa)
-
- Hex:6 HexNAc:2 / N-Linked (avg mass : 1397.2597)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Lysosomal alpha-mannosidase / Homo sapiens
- ANITWSVK (8aa)
- IEHQFAVGEDSGRNISAPVTINIR (24aa)
- NLSAPVTLNLR (11aa)
-
- Hex:7 HexNAc:2 / N-Linked (avg mass : 1559.4021)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Lysosomal alpha-mannosidase / Homo sapiens
- ANITWSVK (8aa)
- TPIVQEVHQNFSAWCSQVVR (20aa)
- GVSEPIMENGSGAWVR (16aa)
-
- Hex:4 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1567.4278)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Lysosomal alpha-mannosidase / Homo sapiens
- TPIVQEVHQNFSAWCSQVVR (20aa)
- INQTEPVAGNYYPVNTR (17aa)
-
- Hex:4 HexNAc:3 dHex:2 / N-Linked (avg mass : 1568.4559)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Lysosomal alpha-mannosidase / Homo sapiens
- INQTEPVAGNYYPVNTR (17aa)
-
- Hex:4 HexNAc:3 dHex:1 NeuAc:1 / N-Linked (avg mass : 1713.5708)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Lysosomal alpha-mannosidase / Homo sapiens
- INQTEPVAGNYYPVNTR (17aa)
-
- Hex:4 HexNAc:3 dHex:3 / N-Linked (avg mass : 1714.5989)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Lysosomal alpha-mannosidase / Homo sapiens
- INQTEPVAGNYYPVNTR (17aa)
-
- Hex:5 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1729.5702)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Lysosomal alpha-mannosidase / Homo sapiens
- INQTEPVAGNYYPVNTR (17aa)
-
- Hex:5 HexNAc:3 dHex:2 / N-Linked (avg mass : 1730.5983)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Lysosomal alpha-mannosidase / Homo sapiens
- INQTEPVAGNYYPVNTR (17aa)
-
- Hex:6 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1891.7126)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Lysosomal alpha-mannosidase / Homo sapiens
- TPIVQEVHQNFSAWCSQVVR (20aa)
-
- Hex:6 HexNAc:3 dHex:2 / N-Linked (avg mass : 1892.7407)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Lysosomal alpha-mannosidase / Homo sapiens
- TPIVQEVHQNFSAWCSQVVR (20aa)
-
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 2224.0231)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Lysosomal alpha-mannosidase / Homo sapiens
- TPIVQEVHQNFSAWCSQVVR (20aa)
-
- Hex:12 HexNAc:2 / N-Linked (avg mass : 2370.1141)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Lysosomal alpha-mannosidase / Homo sapiens
- INQTEPVAGNYYPVNTR (17aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
